SciencePharma
- Company typePrivate
- Founded2004
- HeadquartersWarsaw, Poland
- Headcount51–100
- GTM typeB2B
- OfferingServices
SciencePharma firmographics
Firmographics- Name
- SciencePharma
- Legal name
- SciencePharma spółka z ograniczoną odpowiedzialnością
- Website
- https://sciencepharma.com
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Ownership category
- akta.pro rank
SciencePharma industry classification
Industry- Product category
- Pharmaceutical Consulting Services
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Third-Party/Outsourced Quality & Responsible Person Services (EU QP/RP, US Agent) (HLAGAKAO)
- akta.pro secondary industries
- Manufacturing Quality Assurance & GMP Compliance (batch release, deviation/CAPA, tech transfer QA) (HLAGAKAJ), Quality Engineering & Risk Management (ICH Q9/Q10, validation, change control) (HLAGAKAL), Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD)
Keywords
Where SciencePharma is headquartered
LocationHeadquarters
- HQ city
- Warsaw
- HQ country
- Poland
- HQ region
- Europe
Offices3 records
Markets served
SciencePharma business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Regulatory and Consulting Services: SciencePharma generates revenue primarily through professional consulting services including regulatory affairs (dossier preparation, MA handling, eCTD compilation), pharmacovigilance services (PSMF, ICSR, PSUR), GxP audits (GMP, GCP, GVP, GLP), clinical trial services (CRO services, study setup and conduct), and product development consulting. These are typically project-based or retainer engagements with pharmaceutical companies.
- Import and QP Batch Release Services: Revenue is generated from importing medicinal products from third countries into the EU, including QP batch release certification, storage in GMP-compliant importer warehouse, and supply chain management. Services are provided for both marketed products and IMPs for clinical trials.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom project-based pricing |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
SciencePharma product offering
Product offeringCore offering
SciencePharma provides pharmaceutical consulting and importing services to drug manufacturers and biotech companies. Its offering spans regulatory affairs (dossier preparation, eCTD compilation, MA handling), pharmacovigilance (PSMF, ICSR, PSUR, EU QPPV), GxP audits (GMP, GCP, GVP, GLP), clinical trial services as a CRO, CMC development and quality systems, and Qualified Person (QP) batch release for medicinal products imported from non-EU countries, supported by its own GMP-compliant importer warehouse in Łódź, Poland.
Product overview
SciencePharma is a Polish pharmaceutical consulting and importing services company, founded in 2004 and now part of QbD Group. Its offering is structured as a multi-module consulting services portfolio centered around its own marketed medicinal product line — Neoparin, Neoparin Forte, and Neoparin Multi — for which it serves as the Marketing Authorization Holder. The broader service portfolio consists of six integrated service modules: (1) Product Development Consulting for drug development from early concept to registration; (2) Clinical Trials Services operating as a full-service CRO; (3) Quality Services covering CMC development, GMP system implementation, and batch certification; (4) GxP Audits across GMP, GCP, GVP, and GLP; (5) Regulatory Affairs Services spanning pre-authorization, dossier preparation, eCTD compilation, and post-authorization lifecycle management including OTC switches; and (6) Pharmacovigilance Services including PSMF, RMP, ICSR, PSUR, and EU QPPV service. Additionally, SciencePharma operates a proprietary GMP-compliant importer warehouse in Łódź, Poland, under an MIA (Manufacturer/Importer Authorization) license, offering QP batch release and supply chain management for medicinal products and IMPs imported from non-EU countries. Areas of expertise span medicinal products, IMPs, ATMPs (cell & gene therapy), medical devices, veterinary products, food supplements, and cosmetics.
Differentiator
Problem solved
Functional benefit
Brands
- Neoparin: Medicinal product line including Neoparin, Neoparin Forte, and Neoparin Multi - heparin-based pharmaceutical products.
- Neoparin Forte
- Neoparin Multi
Products and services
- Product Development Consulting
Quantifiable outcome
- Over 1,200 registration dossiers for medicinal products prepared
- +4 more outcomes
Companies that use SciencePharma
Customer profileNamed customers3 records
Segments5 records
Ideal customer profiles3 records
SciencePharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
Feature6 records
SciencePharma partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- QbD GroupcoreSciencePharma is proud to be part of QbD Group – a global life sciences partner supporting companies from idea to patient. By joining forces, SciencePharma combines its strong track record in regulatory affairs, CMC development, and GMP/GDP compliance with QbD Group's broad international expertise across the full product lifecycle. QbD Group has over 600 experts worldwide including a growing presence in Poland and China. SciencePharma continues its operations as part of this expanded group.
Scale indicators9 records
Recent moves6 records
Expansion highlights6 records
SciencePharma competitors and assessment
Company assessmentBroad incumbents
- Parexel International: Large global CRO offering regulatory consulting, pharmacovigilance, and clinical trial services to large pharma. Represents a scaled incumbent competitor for upstream regulatory mandates where SciencePharma also competes.
- Charles River Laboratories: Global CRO offering preclinical, clinical, manufacturing, and regulatory support. Competes with SciencePharma on integrated development programs targeting biotech sponsors.
- IQVIA: World's largest CRO with integrated regulatory, pharmacovigilance, and real-world evidence capabilities. Competes with SciencePharma for mid-to-large pharma regulatory outsourcing contracts across the EU.
- ICON plc: Global CRO and consulting firm providing regulatory, clinical, and pharmacovigilance services. Adjacent competitor for clinical trial and submission support that often co-sells with regulatory consulting.
Direct peers
- QbD Group: Parent company of SciencePharma and direct comparable — a Belgian-headquartered life sciences consulting group offering regulatory affairs, CMC, GMP/GDP compliance, and qualification/validation services across the product lifecycle. Operates as a single integrated firm, with SciencePharma serving as its Poland-led regulatory arm.
- PharmaLex (now part of Cencora/PharmaLex): Global regulatory affairs, pharmacovigilance, and quality consulting firm focused on pharma and biotech. Both firms compete head-to-head for EU MA dossiers, PSMF/RMP setup, and QP/RP services across European markets.
- Arriello: European regulatory affairs and pharmacovigilance consultancy offering dossier preparation, MA lifecycle management, and QP services. Overlaps directly with SciencePharma on EU submission strategy and post-authorization support.
- ProPharma Group: Global consulting and contract service provider for regulatory, pharmacovigilance, and quality compliance in pharma and medical devices. Mirrors SciencePharma's full lifecycle offering from non-clinical through post-marketing.
Regional players
- Vintura: European life sciences consultancy focused on market access, pricing, and commercial strategy. Adjacent regulatory-adjacent peer serving EU biopharma clients with overlapping buyer personas.
Emerging players
- Lambda Therapeutic Research: CRO with regulatory affairs and clinical trial capabilities serving European and emerging markets. Comparable in scale and service mix to SciencePharma with similar non-EU client base.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
SciencePharma social profiles
Digital presenceSciencePharma compliance and trust
Trust signalCompliance3 records
SciencePharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
SciencePharma leadership team
Management profileNumber of profiles
SciencePharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SciencePharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SciencePharma
What does SciencePharma do?
SciencePharma provides pharmaceutical consulting and importing services to drug manufacturers and biotech companies. Its offering spans regulatory affairs (dossier preparation, eCTD compilation, MA handling), pharmacovigilance (PSMF, ICSR, PSUR, EU QPPV), GxP audits (GMP, GCP, GVP, GLP), clinical trial services as a CRO, CMC development and quality systems, and Qualified Person (QP) batch release for medicinal products imported from non-EU countries, supported by its own GMP-compliant importer warehouse in Łódź, Poland.
Is SciencePharma a public or private company?
SciencePharma is a private company. It is classified as corporate owned and is currently operating.
When was SciencePharma founded?
SciencePharma was founded in 2004. It employs 51 to 100 people.
Where is SciencePharma based?
SciencePharma is headquartered in Warsaw, Poland, in the Europe region.
How does SciencePharma make money?
Two revenue lines are on record. Regulatory and Consulting Services are the primary driver. The others are import and QP Batch Release Services.
Who are SciencePharma's main competitors?
Broad incumbents on record are Parexel International, Charles River Laboratories, IQVIA and ICON plc. Direct peers are QbD Group, PharmaLex (now part of Cencora/PharmaLex), Arriello and ProPharma Group. Vintura is listed as a regional player. Lambda Therapeutic Research is listed as an emerging player.
Does SciencePharma have an API?
No public API is recorded for SciencePharma.
What industry is SciencePharma in?
SciencePharma's product category is Pharmaceutical Consulting Services. Its primary akta.pro industry code is HLAGAKAO, Third-Party/Outsourced Quality & Responsible Person Services (EU QP/RP, US Agent), with a secondary code of HLAGAKAJ, Manufacturing Quality Assurance & GMP Compliance (batch release, deviation/CAPA, tech transfer QA). Its NAICS code is 5417 and its SIC code is 8731.